Abstract

Inflammation has been known to be linked to invasion or metastasis of breast cancer, which has poor prognosis, although the regulatory mechanism remains to be undiscovered. Here we show that T-LAK cell-originated protein kinase (TOPK) mediates pro-inflammatory endotoxin lipopolysaccharide (LPS)-induced breast cancer cell migration and invasion. The mRNA or protein level of TOPK, toll- like receptor4 (TLR4), interleukin (IL)-6, vascular endothelial growth factor (VEGF) or matrix metalloproteinase9 (MMP9) genes related to TLR4 signaling or tumor progression was induced by LPS treatment in MCF7 breast cancer cells, but the induction was abolished by stable knocking down of TOPK in MCF7 cells. Also, TOPK depletion decreased LPS-induced phosphorylation of p38, but not ERK and JNK among mitogen-activated protein kinases (MAPKs). On the other hand, we revealed that TOPK is essential for transcriptional activity of NF-κB or MMP9 promoter triggered by LPS. The induced promoter activity of NF-κB or MMP9 but not AP-1 was inhibited by knocking down of TOPK. Furthermore, we demonstrated that inhibitor of TOPK or MMP9 as well as MMP9 siRNA efficiently blocked LPS-induced migration or invasion of breast cancer cell lines. Interestingly, both of expression of TOPK and TLR4 were markedly increased in high-grade breast cancer. Collectively, we conclude that TOPK functions as a key mediator of LPS/TLR4-induced breast cancer cell migration and invasion through regulation of MMP9 expression or activity, implying a potential role of TOPK as a therapeutic target linking LPS-induced inflammation to breast cancer development.

Highlights

  • Lipopolysaccharide (LPS) known as a trigger of inflammatory responses has been suggested to be implicated in several cancer invasion or angiogenesis [1,2,3]

  • Results showed that protein or mRNA level of T-LAK cell-originated protein kinase (TOPK) was increased dose-dependently in response to LPS in MCF7 cells, and toll- like receptor4 (TLR4), LPS specific receptor, expression was elevated by LPS treatment (Figure 1A and 1B)

  • We investigated the correlation of TOPK with genes related to angiogenesis, cell invasion or TLR4 signaling pathway, involving matrix metalloproteinase9 (MMP9), vascular endothelial growth factor (VEGF), myeloid differentiation factor 88 (MyD88), or interleukin-6 (IL-6)

Read more

Summary

Introduction

Lipopolysaccharide (LPS) known as a trigger of inflammatory responses has been suggested to be implicated in several cancer invasion or angiogenesis [1,2,3]. Recent studies indicated that toll-like receptors (TLRs) are expressed in many tumors and might play key roles in tumor progression. The role of TLR4, specific receptor for LPS, in tumor progression has been studied in various cancers involving colon, pancreas, liver and breast cancers [4,5,6,7]. It has been shown that LPS/TLR4 has critical role in stimulation of invasiveness of breast cancer cells, and status of TLR4 expression is deeply linked to metastasis [6]. Little is known about the underlying mechanism by which LPS/TLR4 regulates breast cancer progression involving migration, invasion or metastasis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call